Moore J A, Burket M W, Puri S, Temesy-Armos P, Lachant N, Skeel R
Department of Internal Medicine, Medical College of Ohio, Toledo.
Cathet Cardiovasc Diagn. 1994 Jul;32(3):286-7. doi: 10.1002/ccd.1810320320.
Ancrod is a rapid-acting defibrinogenating agent derived from the venom of the Malayan pit viper which has been used successfully as an alternative to heparin sulfate for anticoagulation during peripheral vascular procedures and coronary artery bypass surgery. We describe the first use of ancrod for anticoagulation before and during percutaneous transluminal coronary angioplasty (PTCA) in a patient with heparin-associated thrombocytopenia.
安克洛酶是一种速效去纤维蛋白原剂，由马来亚蝰蛇的毒液提取而来，已成功用作外周血管手术和冠状动脉搭桥手术中肝素的替代品用于抗凝。我们描述了在一名患有肝素相关性血小板减少症的患者经皮腔内冠状动脉成形术（PTCA）之前及术中首次使用安克洛酶进行抗凝的情况。
